News & Views
PRECOS Appoints Dr Neil Rotherham as Chairman
Nov 24 2010
Preclinical Oncology Services Limited (PRECOS), announces the appointment of Dr Neil Rotherham as Chairman of the Board. Dr Rotherham has over 20 years’ leadership experience in the life sciences, medical, pharmaceutical and biopharmaceutical sectors. He was responsible for developing and growing ClinPhone plc, from a twoperson start-up in 1993 to a 500-person global venture that was listed on the London Stock Exchange in 2006. Dr Rotherham left the business after bringing through a management team to run the business subsequent to going public.
"PRECOS combines the innovation of one of the Country’s leading universities (Nottingham) with the scientific background and expertise of multi-disciplinary scientists." said Dr Rotherham. "This places the company in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs." He continues: "PRECOS occupies a niche in global pre-clinical R&D working with unique patient-relevant models closely reflecting the patient situation. Tumour development can be monitored in real-time, allowing companies to concentrate efforts on those compounds most likely to have a therapeutic effect in patients with cancer."
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE